Intuitive Surgical (Intuitive Surgical) ROCE %

: 13.43% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Intuitive Surgical's annualized ROCE % for the quarter that ended in Dec. 2023 was 13.43%.

Intuitive Surgical ROCE % Historical Data

The historical data trend for Intuitive Surgical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intuitive Surgical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

17.48

11.11

16.11

13.17

13.95

Intuitive Surgical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %																12.64	13.31	15.37	14.67	13.43

Intuitive Surgical ROCE % Calculation

Intuitive Surgical's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	1766.8	/	( ( (12974 - 1422.1)	+	(15441.5 - 1658.7) )	/ 2 )
	=	1766.8	/	( (11551.9	+	13782.8)	/ 2 )
	=	1766.8	/	12667.35
	=	13.95 %

Intuitive Surgical's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	1800.8	/	( ( (14712.7 - 1676.4)	+	(15441.5 - 1658.7) )	/ 2 )
	=	1800.8	/	( ( 13036.3	+	13782.8 )	/ 2 )
	=	1800.8	/	13409.55
	=	13.43 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Intuitive Surgical (NAS:ISRG) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Intuitive Surgical ROCE % Related Terms

Thank you for viewing the detailed overview of Intuitive Surgical's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Intuitive Surgical (Intuitive Surgical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Intuitive Surgical Inc (NAS:ISRG) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

ISRG:Mexico 1ISRG:Italy IUI1:Germany IUI1:Germany IUI1:Germany IUI1:Germany I1SR34:Brazil ISRG:Austria

Address

1020 Kifer Road, Sunnyvale, CA, USA, 94086-5304

Website

https://www.intuitive.com

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,000 da Vinci systems in hospitals worldwide, with nearly 5,000 installations in the U.S. and a growing number in emerging markets.

Executives

Alan J Levy	director	C/O INTUITIVE SURGICAL INC, 1266 KIFER RD, SUNNYVALE CA 94086
Robert Desantis	officer: Executive VP & GM IA&E	C/O INTUITIVE SURGICAL, INC., 1020 KIFER ROAD, SUNNYVALE CA 94086
Sreelakshmi Kolli	director	C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131
Gary S Guthart	director, officer: President & CEO, other: President & CEO	C/O INTUITIVE SURGICAL INC, 1266 KIFER RD, SUNNYVALE CA 94086
Amy L Ladd	director	INTUITIVE SURGICAL, INC, 1020 KIFER RD, SUNNYVALE CA 94086
Craig H Barratt	director
Marshall Mohr	officer: SVP & CFO	C/O INTUITIVE SURGICAL, INC, 1266 KIFER ROAD, SUNNYVALE CA 94086
Mark J Rubash	director
David J. Rosa	officer: Sr VP Emerging Procedures & Te	1266 KIFER ROAD, SUNNYVALE CA 94086
Fredrik Widman	officer: VP Corporate Controller	1020 KIFER ROAD, 1020 KIFER ROAD, SUNNYVALE CA 94086
Myriam Curet	officer: SVP & Chief Medical Officer, other: SVP & Chief Medical Officer	1020 KIFER ROAD, SUNNYVALE CA 94086
Michele Dimartino	officer: See Remarks	1020 KIFER ROAD, SUNNYVALE CA 94086
Amal M Johnson	director	C/O MELLANOX TECHNOLOGIES, INC., 350 OAKMEAD PARKWAY, SUITE 100, SUNNYVALE CA 94085
Gary Loeb	officer: General Counsel & CCO	5885 HOLLIS ST., SUITE 100, EMERYVILLE CA 94608
Henry L Charlton	officer: Senior Vice President & Chief	1020 KIFER ROAD, 1020 KIFER ROAD, SUNNYVALE CA 94086